Who
August J. Moretti
Director
Company insider
Files Form 4 as: Director, Vivani Medical; Director, Cibus; Chief Financial Officer, 4D Molecular Therapeutics; Chief Financial Officer & SVP, Depomed; Former SVP, CFO, GC & Sec, Alexza Pharmaceuticals.
In numbers
- Trades disclosed
- 144
- Buys
- 0
- Sells
- 19
- Bought
- $0
- Sold
- $1.1M
- Companies
- 5
- Companies where not an officer
- 2
- First trade
- 29 Aug 2006
- Last trade
- 24 Jun 2026
- Last filed
- 26 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 24 Jun 2026filed 26 Jun 2026 | VANI Vivani Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | $44K36,000 at $1.22 | filing |
| 24 Jun 2026filed 26 Jun 2026 | VANI Vivani Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | $44K36,000 at $1.22 | filing |
| 2 Jun 2026filed 4 Jun 2026 | CBUS Cibusoption or derivative · Agricultural Chemicals & Fertilizers | SEC FORM 4 Code A | —77,586 at $0.00 | filing |
| 2 Jun 2026filed 4 Jun 2026 | CBUS Cibusoption or derivative · Agricultural Chemicals & Fertilizers | SEC FORM 4 Code A | —77,586 at $0.00 | filing |
| 22 May 2025filed 27 May 2025 | CBUS Cibusoption or derivative · Agricultural Chemicals & Fertilizers | SEC FORM 4 Code A | —39,301 at $0.00 | filing |
| 20 Nov 2024filed 25 Nov 2024 | CBUS Cibusoption or derivative · Agricultural Chemicals & Fertilizers | SEC FORM 4 Code A | —14,733 at $0.00 | filing |
| 15 May 2023filed 16 May 2023 | FDMT 4D Molecular Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,000 at $0.00 | filing |
| 15 May 2023filed 16 May 2023 | FDMT 4D Molecular TherapeuticsBiotechnology | SEC FORM 4 Code M | $28K3,000 at $9.41 | filing |
| 10 Feb 2023filed 14 Feb 2023 | FDMT 4D Molecular Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 21 Dec 2022filed 22 Dec 2022 | FDMT 4D Molecular Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,000 at $0.00 | filing |
| 21 Dec 2022filed 22 Dec 2022 | FDMT 4D Molecular TherapeuticsBiotechnology | SEC FORM 4 Code M | $28K3,000 at $9.41 | filing |
| 1 Sep 2022filed 6 Sep 2022 | FDMT 4D Molecular Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 1 Feb 2022filed 3 Feb 2022 | FDMT 4D Molecular Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —65,000 at $0.00 | filing |
| 12 Apr 2021filed 14 Apr 2021 | FDMT 4D Molecular TherapeuticsBiotechnology | SEC FORM 4 Code M | $9,4101,000 at $9.41 | filing |
| 12 Apr 2021filed 14 Apr 2021 | FDMT 4D Molecular Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,000 at $0.00 | filing |
| 8 Mar 2021filed 10 Mar 2021 | FDMT 4D Molecular Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —70,000 at $0.00 | filing |
| 31 Mar 2018filed 3 Apr 2018 | Depomed | SEC FORM 4 Code F | $46K6,975 at $6.59 | filing |
| 18 Dec 2017filed 20 Dec 2017 | Depomedoption or derivative | SEC FORM 4 Code D | —55,000 at $0.00 | filing |
| 18 Dec 2017filed 20 Dec 2017 | Depomedoption or derivative | SEC FORM 4 Code D | —92,500 at $0.00 | filing |
| 18 Dec 2017filed 20 Dec 2017 | Depomedoption or derivative | SEC FORM 4 Code D | —54,200 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.